Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Non-Current Deferred Tax Liability came in at $18.0 million in Q2 2026, up 28.57% YoY from $14.0 million in Q2 2025, and down 5.26% on a QoQ basis from $19.0 million in Q1 2026.
Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $18.0 million in Q2 2026.
- Quarterly Non-Current Deferred Tax Liability rose 28.57% year-over-year to $18.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.0 million (up 28.57% YoY) and the FY2025 annual result came in at $19.0 million, down 83.62% from the prior year.
- Non-Current Deferred Tax Liability retreated to $18.0 million in Q2 2026, from $19.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $118.0 million in Q4 2023 to a low of $10.0 million in Q2 2022.
- A 5-year average of $36.1 million and a median of $14.0 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 120.75% — and 2023, when it slumped 86.41%.
- Tracing BLCO's Non-Current Deferred Tax Liability over 5 years: stood at $117.0 million in 2022, then advanced by 0.85% to $118.0 million in 2023, then slipped by 1.69% to $116.0 million in 2024, then slumped by 83.62% to $19.0 million in 2025, then decreased by 5.26% to $18.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $18.0 million (Q2 2026), $19.0 million (Q1 2026), and $19.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.00 Mn |
| Jun 30, 2026 | 18.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 116.00 Mn |
| Dec 31, 2024 | 116.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |